Figure 3From: Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistanceKaplanāMeier curve of overall survival of lung adenocarcinoma patients with low and high Ku80 expression. (A) KaplanāMeier analysis of tumor-specific overall survival in all lung adenocarcinoma patients according to Ku80 protein level. The 5-year survival probability was 94.4% for the patients with low Ku80 protein level (nā=ā23), and 79.8% for patients with high Ku80 protein level (nā=ā83). (B) KaplanāMeier analysis of progression-free survival according to Ku80 protein level. The progression-free survival interval was 45.56āĀ±ā3.85 (95% CI: 37.99-53.12) months for the patients with low Ku80 protein level (nā=ā23), and 20.18āĀ±ā1.72 (95% CI: 16.81-23.54) for patients with high Ku80 protein level (nā=ā83).Back to article page